Invirsa has a total of 45 patents globally, out of which 23 have been granted. Of these 45 patents, more than 93% patents are active. United States of America is where Invirsa has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Invirsa.
Invirsa was founded in the year 2016. The Company operates as a pharmaceutical company. The Company focuses on enhancing the body’s natural defenses to both protect and fight with infectious diseases. Invirsa serves customers in the State of Ohio.
Do read about some of the most popular patents of Invirsa which have been covered by us in this article and also you can find Invirsa patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Invirsa patent portfolio.
How many patents does Invirsa have?
Invirsa has a total of 45 patents globally. These patents belong to 2 unique patent families. Out of 45 patents, 42 patents are active.
How Many Patents did Invirsa File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Invirsa Applications Filed | Invirsa Patents Granted |
| 2024 | – | 2 |
| 2023 | 4 | 8 |
| 2022 | 1 | 5 |
| 2021 | 5 | 7 |
| 2019 | 10 | – |
| 2018 | 2 | 1 |
| 2017 | 23 | – |
How many Invirsa patents are Alive/Dead?
How Many Patents did Invirsa File in Different Countries?
Countries in which Invirsa Filed Patents
| Country | Patents |
| Japan | 5 |
| United States Of America | 5 |
| Europe | 4 |
| Hong Kong (S.A.R.) | 3 |
| Italy | 2 |
| South Korea | 2 |
| Germany | 2 |
| Austria | 2 |
| Spain | 2 |
| Israel | 2 |
| Australia | 2 |
| Portugal | 1 |
| Indonesia | 1 |
| Hungary | 1 |
| Denmark | 1 |
| Poland | 1 |
| Brazil | 1 |
| China | 1 |
| Canada | 1 |
| Croatia | 1 |
| Lithuania | 1 |
| Norway | 1 |
| India | 1 |
Where are Research Centres of Invirsa Patents Located?
The Research Centre for all the Invirsa patents is the United States of America.
What Percentage of Invirsa US Patent Applications were Granted?
Invirsa (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Invirsa patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Invirsa?
| Law Firm | Total Applications | Success Rate |
| Jones Day | 3 | 100.00% |
List of Invirsa Patents
| Invirsa Patents | Title |
| US11857561B2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| US11793826B2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| US11110112B2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| US10946034B2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| US20230414647A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| EP3773604B1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| EP3416654B1 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| EP4226971A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| EP3978003A1 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| CN108601793A | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| ES2949441T3 | Methods For The Use Of 5”-Adenosine Diphosphate Ribose (Adpr) |
| DE602019027747T2 | Method Of Use Of 5′-Adenosindiphosphatribose (Adpr) |
| IT202300033384T2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| ES2900524T3 | Methods For The Use Of 5”-Adenosine Diphosphate Ribose (Adpr) |
| DE602017048212T2 | Medical Use Of 5′-Adenosindiphosphatribose (Adpr) |
| IT202100102809T2 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr). |
| AT1441210T | Medizinische Verwendung Von 5′-Adenosindiphosphatribose (Adpr) |
| PL3416654T3 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| HRP20211942T1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| DK3416654T3 | Medical Uses Of 5′-Adenosindiphosphatribose (Adpr) |
| NO3416654B1 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| HUE057052T2 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| LT3416654T | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| PT3416654T | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| JP7242696B2 | How To Use 5′-Adenosine Diphosphate Ribose (Adpr) |
| JP7222042B2 | How To Use 5′-Adenosine Diphosphate Ribose (Adpr) |
| JP6946353B2 | How To Use 5′-Adenosine Diphosphate Ribose (Adpr) |
| JP2023071933A5 | How To Use 5’-Adenosine Diphosphate Ribose (Adpr) |
| JP2023055858A5 | How To Use 5′-Adenosine Diphosphate Ribose (Adpr) |
| HK40041244A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| HK40073052A | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| HK1263210A1 | Medical Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| KR102622656B1 | Methods Of Using 5′-Adenosine Diphosphate Ribose (Adpr) |
| AU2017219878B2 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| IL261095B | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| KR1020230148389A | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| AU2023201678A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| IL291574A | Methods For The Use Of 5′-Adenosine Diphosphate Ribose |
| IN432092B | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| BR112018016398A2 | Methods For Using 5′-Adenosine Diphosphate Ribose (Adpr) |
| ID201810969A | Methods For Use 5′-Adenosine Diphosphate Ribose (Adpr) |
| CA3014071A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| AT1560705T | Verfahren Zur Verwendung Von 5′-Adenosindiphosphatribose (Adpr) |
| WO2019191026A3 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
| WO2017143113A1 | Methods For The Use Of 5′-Adenosine Diphosphate Ribose (Adpr) |
What are Invirsa key innovation segments?
What Technologies are Covered by Invirsa?
The chart below distributes patents filed by Invirsa